It's a joke-20+ year old drug with a shitty marketing team that can't even hold a national conference call without falling all over each other, reimbursement has slipped and not easy to get drug, nothing new from marketing to use so docs are bored and irritated with 4 of us coming in
It's a joke-20+ year old drug with a shitty marketing team that can't even hold a national conference call without falling all over each other, reimbursement has slipped and not easy to get drug, nothing new from marketing to use so docs are bored and irritated with 4 of us coming in
When JC gets approval for fortune cookies to admin with Enbrel, we will get all market share and price like it's an oncology drug. JC will save the day, just you watch.
Enbrel is growing like Mad crazy killing Humira and getting new indications for genitalia enlargement. New management Jay Chiang is a real winner from McKinsey and setting Enbrel for launch in oncology as well.
